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The Human Cutaneous Squamous Cell Carcinoma
Microenvironment Is Characterized by Increased
Lymphatic Density and Enhanced Expression of
Macrophage-Derived VEGF-C
Dariush Moussai1, Hiroshi Mitsui2, Julia S. Pettersen1, Katherine C. Pierson2, Kejal R. Shah2,
Mayte Sua´rez-Farin˜as2,3, Irma R. Cardinale2, Mark J. Bluth1, James G. Krueger2 and John A. Carucci1
Metastases from primary cutaneous squamous cell carcinoma (SCC) account for the majority of the B10,000
non-melanoma skin cancer deaths in the United States annually. We studied lymphangiogenesis in human SCC
because of the potential link to metastasis. SCC samples were stained for lymphatic endothelial vessel marker
LYVE-1 and positive cells were counted and compared with cells in normal skin. Gene set enrichment analysis
and reverse transcription (RT)-PCR were performed on SCC, on adjacent non-tumor-bearing skin, and on
normal skin to determine the differential expression of lymphangiogenesis-associated genes. Laser capture
microdissection (LCM) was performed to isolate tumor cells and tumor-associated inflammatory cells for
further gene expression analysis. Immunofluorescence was performed to determine the source of vascular
endothelial growth factor-C (VEGF-C) in the tumor microenvironment. We found increased lymphatic density
and reorganized lymphatic endothelial vessels in the dermis immediately adjacent to SCC nests. RT-PCR
confirmed the presence of VEGF-C in skin immediately adjacent to SCC. LCM confirmed the increased
expression of VEGF-C, the SCC inflammatory infiltrate. The presence of CD163þ /CD68þ /VEGFCþ cells and
absence of VEGF-C expression by CD3þ or CD11Cþ cells suggested that VEGF-C is derived from tumor-
associated macrophages. Clarification of mechanisms governing SCC-mediated lymphangiogenesis may
identify potential targets for therapeutic intervention against aggressive or inoperable disease.
Journal of Investigative Dermatology (2011) 131, 229–236; doi:10.1038/jid.2010.266; published online 9 September 2010
INTRODUCTION
Squamous cell carcinoma (SCC), the second most common
human cancer, affects nearly 300,000 individuals and
accounts for the majority of approximately 10,000 deaths
due to non-melanoma skin cancer in the United States each
year (Weinberg et al., 2007). Cutaneous SCC is often cured
by excision with clear margins; however, SCC can behave
aggressively, resulting in nodal metastases through regional
lymphatics. Lymphatic invasion has been used in the tumor
node metastasis staging of lung, breast, and prostate cancer
(Edge and Compton et al., 2010). Invasion of local lymphatics
by head and neck SCC is associated with unfavorable
prognosis (Veness et al., 2006). Baek et al. (2009) showed
that increased lymphatic vessel density (LVD) and vascular
endothelial growth factor-C (VEGF-C) expression were
predictors for lymph node metastasis in supraglottic SCC.
VEGF-C expression and increased LVD also correlated with
risk of metastasis with oral SCC (Sugiura et al., 2009). The
role of increased LVD and VEGF-C expression in human
cutaneous SCC is not fully understood.
We studied lymphangiogenesis in cutaneous SCC to
determine whether new lymphatic vessel formation was
detectable in stage 1 disease. We found increased LVD in
SCC and upregulation of lymphangiogenesis genes. Overall,
we found (1) that SCC is associated with increased density of
lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1þ )
lymphatic endothelial cells (LECs); (2) increased expression
of IL-8 in SCC tumor and increased expression of VEGF-C,
coreceptor neuropilin-2 (NRP-2), and LEC surface glyco-
protein podoplanin (PDPN) in peritumoral skin; (3) that
VEGF-C is significantly upregulated in inflammatory cells
surrounding SCC; and (4) that CD163þCD68þVEGF-Cþ
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cells surround SCC, suggesting that peritumoral macrophages
may be a source of VEGF-C in the tumor microenviron-
ment. Further elucidation of the mechanisms involved in
lymphangiogenesis adjacent to SCC may lead to the
development of novel therapeutics for locally aggressive
or inoperable SCC.
RESULTS
Cutaneous SCC is associated with increased LVD
We investigated whether cutaneous SCCs were routinely
associated with increased LVD in the juxtatumoral area,
potentially providing increased access to local lymphatics
and ultimately to regional lymph nodes. To determine
whether SCC was associated with increased density of
LECs, we stained slides from SCC (N¼ 10) and normal skin
(N¼10) with LEC-specific marker LYVE-1; positive cells were
counted in the juxtatumoral dermis around tumor nests
(Figure 1a and b). An example of LYVE-1-stained SCC is
shown (Figure 1a) compared with normal skin (Figure 1b).
We found elevated levels of LYVE-1þ cells in SCC
(B1.5-fold) compared with normal skin (Po0.05, Figure 1c).
Therefore, we wondered whether they expressed the VEGF-C
receptor-3 (VEGFR-3) in human skin (Hamrah et al., 2003).
We found colocalization of VEGFR-3 with LYVE-1 in SCC
by immunofluorescence microscopy (Figure 1d). LYVE-1þ
cells were not positive for PAL-E or CD34 (Supplementary
Figure S1 online). This confirms the presence of VEGFR-3þ
LECs adjacent to SCC.
SCC is characterized by upregulation of
lymphangiogenesis-associated gene sets
We evaluated fold change of expression of angiogenesis,
lymphangiogenesis, and VEGF gene pathways for SCC,
peritumoral non-lesion (PTNL), and normal skin, as described
in Materials and Methods section. Mean fold change analysis
showed statistically significant increase in the Iritani _LEC
gene set in PTNL versus normal skin (P¼ 0.0007, Figure 2).
We did not find a statistically significant change with
Brentani Angiogenesis and VEGFPATHWAY gene sets. It
may be that the Brentani and VEGFPATHWAY sets are more
reflective of blood vessel angiogenesis rather than of
proliferation of LECs. This may also reflect the fact that the
Iritani set is broader with 127 genes and the Brentani and
VEGFPATHWAY sets are narrower with 10 and 28 genes,
respectively. We performed gene set enrichment analysis
analyses for SCC, PTNL, and normal skin gene sets that were
previously described by our group (Haider et al., 2006). The
Iritani_LEC set showed elevated expression in SCC compared
with normal skin (normalized enrichment score¼1.61,
P¼0.001) (Table 1). Similarly, we found upregulation of
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Figure 1. Human cutaneous SCC is associated with increased lymphatic
vessel density and characterized by the expression of LYVE-1 and VEGFR-3.
Representative immunohistochemistry of LYVE-1 expression in (a) SCC and
(b) normal skin. (c) Mean LYVE-1þ cell counts with standard error of the
mean in SCC (black bar) and normal skin (gray bar) (n¼ 10 for both groups).
*Po0.05. (d) Immunofluorescence revealed colocalization of LYVE-1 (green)
and VEGFR-3 (red) in SCC lymphatic endothelial cells. Scale bar¼100 mm.
LYVE-1, lymphatic vessel endothelial hyaluronan receptor-1; SCC, squamous
cell carcinoma; VEGFR-3, vascular endothelial growth factor receptor-3.
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the Iritani_LEC set in PTNL skin compared with normal skin
(normalized enrichment score¼ 1.78, P¼0.0001). This
indicates activation corresponding to a set of 127 LEC genes
from SCC and PTNL adjacent to SCC.
Peritumoral skin shows expression of LEC-specific VEGF-C,
coreceptor NRP-2, and LEC surface glycoprotein PDPN
by RT-PCR
We studied the expression of lymphangiogenesis growth
factors and cognate receptors in SCC, PTNL, and normal skin
by reverse transcription (RT)-PCR. These included VEGF-C,
VEGF-D, VEGF-C receptor VEGFR-3 (Flt-4), coreceptor NRP-2,
LEC surface glycoprotein PDPN, lymphangiogenesis transcrip-
tion factor PROX-1, and IL-8. We found elevated expression
of VEGF-C in SCC and PTNL compared with normal skin
(Po0.05, Figure 3a). We also found elevated expression
of NRP-2 and PDPN in PTNL compared with normal skin
(Po0.05, Figure 3e and f). Flt-4 was increased in PTNL skin
but this did not reach statistical significance (Figure 3d).
These results demonstrate increased expression of factors that
mediate lymphangiogenesis in the skin immediately adjacent
to SCC within 1–2mm of the clear excision margin.
Laser capture microscopy shows increased expression
of VEGF-C by inflammatory cells associated with SCC
Microarray and RT-PCR analyses provided information
regarding expression of lymphangiogenesis-associated factors
in the tumor microenvironment as a unit. We performed laser
capture microdissection (LCM) to define the production of
VEGF-C in actinic keratosis (AK)-like dysplasia versus SCC
in situ versus invasive SCC versus inflammatory cells adjacent
to invasive SCC (Supplementary Figure S2 online). We found
significantly higher levels of VEGF-C expressed by inflam-
matory cells (Figure 4d). This is consistent with the VEGF-C
staining localized to the inflammatory infiltrate by immuno-
histochemistry (Supplementary Figure S3c online). VEGF-C
was not highly expressed in AK-like dysplasia. VEGF-D was
more highly expressed in SCC in situ compared with invasive
SCC (Supplementary Figure S4a online). VEGF-D expression
was increased in inflammatory infiltrate, although this was
not statistically significant (Po0.0571). These findings
suggest that the inflammatory cells associated with SCC
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Figure 2. Lymphatic endothelial cell (LEC)-associated gene signatures are present in squamous cell carcinoma (SCC) and in adjacent non-tumor-bearing
skin compared with normal skin. The mean log fold change of published cancer-related angiogenic (Brentani), LEC-specific (Iritani_LEC), and vascular
endothelial growth factor (VEGF) (VEGFPATHWAY) gene sets for SCC versus normal skin (black bars), peritumoral non-lesion (PTNL) versus normal skin
(dark gray bars), and SCC versus PTNL (light gray bars). In the Iritani gene set, PTNL versus normal skin showed increased expression. **Po0.005.
Table 1. Gene set enrichment analysis of lymphatic
endothelial cell genes, cancer-related angiogenesis
genes, and vascular endothelial growth factor (VEGF)
pathway genes in SCC and PTNL skin compared with
normal skin
NES P-value FDR
SCC versus normal
Iritani_Adprox_Lymphatic EC 1.61 0.001 0.032
Brentani_Angiogenesis 1.3 0.179 0.13
VEGFPATHWAY 0.77 0.8 0.842
SCC versus PTNL
Iritani_Adprox_Lymphatic EC 1.27 0.081 0.155
Brentani_Angiogenesis 1.47 0.089 0.102
VEGFPATHWAY 1.17 0.272 0.24
PTNL versus normal
Iritani_Adprox_Lymphatic EC 1.78 0.0001 0.002
Brentani_Angiogenesis 1.09 0.382 0.304
VEGFPATHWAY 0.95 0.511 0.533
Abbreviations: FDR, false discovery rate; LEC, lymphatic endothelial
cell; NES, normalized enrichment score; PTNL, peritumoral non-lesional;
SCC, squamous cell carcinoma.
LEC-specific (Iritani_Adprox_Lymphatic EC), angiogenesis-specific (Brentani_
angiogenesis), and VEGF-specific (VEGFPATHWAY) gene sets were
compared in three different biological conditions: SCC versus normal,
SCC versus PTNL, and PTNL versus normal. LEC-specific gene set was
significantly enriched in SCC and PTNL skin compared with normal
(NES=1.61 and 1.78, respectively).
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might be a source of VEGF-C in the tumor microenvironment
and that VEGF-D might be involved in lymphangiogenesis at
an early point in tumor development.
Immunofluorescence microscopy shows the presence
of tumor-associated macrophages that express VEGF-C
Increased expression of VEGF-C by inflammatory cells has
been associated with invasive carcinoma (Hirakawa et al.,
2007). As previous studies have established a potential role
for macrophage-derived VEGF-C in inflammatory lymphan-
giogenesis (Kataru et al., 2009; Watari et al., 2008;
Schoppmann et al., 2002), we used immunofluorescence
microscopy to determine whether tumor-associated macro-
phages produce VEGF-C. We chose CD163 and CD68 as
surface markers as they are coexpressed in normal skin
macrophages (Zaba et al., 2007). We found CD163þ /VEGF-
Cþ and CD68þ /VEGF-Cþ cells surrounding SCC (Figure 4a
and b). No cells coexpressed CD3 or CD11c with VEGF-C
(Supplementary Figure S3a, b online). As both CD163þ and
CD68þ showed VEGF-C positivity, we wondered whether
SCC-associated macrophages expressed all three markers.
Results of triple stain immunofluorescence showed cells that
expressed VEGF-C (red), CD68 (green), and CD163 (blue),
with triple-stained (CD163þCD68þVEGF-Cþ ) cells shown
as white (Figure 4c). CD163þ cells also showed VEGF-D
positivity on immunofluorescence microscopy (Supplemen-
tary Figure S4b online). Our findings suggest that SCC-
associated macrophages may be an important source of
factors mediating lymphangiogenesis.
DISCUSSION
Several findings stand out from these studies: (1) cutaneous
SCC is associated with increased LVD in the juxtatumoral
dermis; (2) peritumoral skin adjacent to SCC showed
increased expression of VEGF-C, coreceptor NRP-2, and
LEC-specific glycoprotein PDPN; (3) VEGF-C was upregu-
lated in inflammatory cells associated with invasive SCC;
(4) CD163þCD68þVEGF-Cþ cells surround SCC supporting
the potential role of tumor-associated macrophages in pro-
moting lymphangiogenesis in the tumor microenvironment.
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Figure 3. Vascular endothelial growth factor (VEGF)-C, VEGF-D, Prox-1, Flt-4, neuropilin-2 (NRP-2), podoplanin (PDPN), and IL-8 are expressed
in the squamous cell carcinoma (SCC) microenvironment. The relative mRNA expression of (a) VEGF-C, (b) VEGF-D, (c) PROX-1, (d) Flt-4, (e) NRP-2,
(f) PDPN, and (g) IL-8 relative to human acidic ribosomal protein in SCC (black bars), peritumoral non-lesion (PTNL, gray bars), and normal skin (white bars).
Data are expressed as relative gene expressionþ SEM. *Po0.05, ***Po0.0005.
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Lymphangiogenesis in cutaneous SCC is not fully under-
stood. Human dermal lymphatic vessels express lymphatic
vessel endothelial hyaluronan receptor-1, LYVE-1, a CD44
homolog that binds to hyaluronic acid in the extracellular
matrix (Banerji et al., 1999). We found increased LVD by
LYVE-1 staining in the juxtatumoral dermis adjacent to SCC.
VEGF-C primarily drives lymphangiogenesis, although it has
been shown to drive neovascularization in mouse cornea
(Cao et al., 1998). In addition, Groger et al. (2007), showed
that blood endothelial cells can be induced to express
LYVE-1. In our studies involving human SCC, we found that
LYVE-1þ cells did not express CD34 or PAL-E, indicating
increased LVD in the dermis adjacent to SCC (Supplementary
Figure S1 online). LVD determined by LYVE-1 or VEGFR-3
may be a prognostic indicator in human cancers. For
example, LYVE-1 expression in breast cancer is associated
with poor prognosis (Bono et al., 2004). Increased VEGF-C,
VEGF-D, and LVD also correlate risk of metastasis with oral
SCC (Sugiura et al., 2009) and melanoma (Boone et al.,
2008), supporting the potential importance of increased LVD
in cutaneous SCC.
We found increased density of LYVE-1þ LECs in primary
cutaneous SCC, along with increased expression of lymphan-
giogenesis genes in SCC and in immediately adjacent non-
tumor-bearing skin. The increased LVD is in close proximity
to the immediately adjacent non-tumor-bearing skin. These
‘‘non-lesional’’ regions adjacent to the tumor appear as
normal skin by light microscopy; however, the gene
expression pattern shows the potential for enhanced lym-
phangiogenesis. Increased dermal lymphangiogenesis may
facilitate metastasis, despite seemingly clear excision mar-
gins. Frech et al. (2009) recently showed higher peritumoral
LVD compared with intratumoral LVD in head and neck SCC.
This is consistent with our own findings of increased LVD in
cutaneous SCC and increased expression of VEGF-C and
lymphangiogenesis genes in the PTNL.
VEGF-C is a critical lymphangiogenesis mediator (Karpa-
nen et al., 2001). Binding of VEGF-C or VEGF-D to VEGFR-3
initiates a signal-transduction cascade, including the activa-
tion of the JNK/Erk pathway, culminating in the proliferation
and survival of LECs via Prox-1 (Hamada et al., 2000). We
observed higher levels of VEGF-C in the tumor and in
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Figure 4. Squamous cell carcinoma (SCC)-associated macrophages express vascular endothelial growth factor-C (VEGF-C). (a) CD163þ macrophages (green)
and (b) CD68þ macrophages (green) colocalized with VEGF-C (red) shown as yellow. (c) Triple-labeled immunofluorescence revealed the presence of CD163þ
cells (blue) that expressed both CD68 (green) and VEGF-C (red). Triple-positive cells (CD163þCD68þVEGF-Cþ ) appear white. Scale bar¼ 100 mm. (d) VEGF-C
mRNA expression in normal epidermis (EPI, n¼3), actinic keratosis (AK)-like dysplasia (AK-like dysplasia, n¼3), SCC in situ (SCCIS, n¼3), invasive SCC
(n¼3), and inflammatory infiltrate (INF, n¼5). Po0.01 for the following comparisons with VEGF-C: INF versus normal epidermis, INF versus AK-like dysplasia,
and INF versus SCCIS.
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matched adjacent non-tumor-bearing skin compared with
normal skin (Figure 3a). VEGF-A is critical in mediating
angiogenesis and important in lymphangiogenesis as well
(Cursiefen et al., 2004). We previously found elevated levels
of VEGF-A in the juxtatumoral dermis of SCC compared with
normal skin by RT-PCR (Bluth et al., 2009).
NRP-2 is expressed in LECs and can function as a corecep-
tor with VEGFR-3 or VEGFR-2 to bind VEGF-C/VEGF-D
(Favier et al., 2006). NRP-2 blockade abrogated tumor
metastasis, supporting its potential importance as a pharma-
cological target (Caunt et al., 2008). We found elevated levels
of NRP-2 in peritumoral skin adjacent to SCC (Figure 3e). As
NRP-2 might be expressed on cutaneous veins (Yuan et al.,
2002), one must consider that the increase may be partly due
to increased blood vessel angiogenesis in the tumor micro-
environment. It may be that, in our system, factors from the
tumor or from elsewhere in the SCC microenvironment
upregulate expression of lymphangiogenesis mediators in
skin immediately adjacent to SCC, thus providing a pathway
for metastasis.
PDPN is a surface sialomucin glycoprotein on LECs
recognized by D2-40 antibody, commonly used to stain
lymphatic vessels. Although its function is incompletely
understood, it has a key role in lymphatic vessel adhesion
through binding to galectin-8 (Cueni and Detmar, 2009). We
found increased expression of PDPN in PTNL compared with
normal skin, consistent with the increased LVD observed in
our studies (Figure 3f). IL-8 (CXCL-8) is a monocyte-derived
chemokine that mediates influx of granulocytes and promotes
angiogenesis (Rosenkilde and Schwartz, 2004). We observed
significant expression of IL-8 in SCC (Figure 3g), supporting
its role in the establishment of the inflammatory tumor
microenvironment.
Some lymphangiogenesis genes did not show statistically
significant increased expression in the PTNL. Prox-1 is a key
transcription factor and critical in lymphangiogenesis (Wigle
and Oliver, 1999). We observed increased expression of
Prox-1 adjacent to SCC; however, this was not statistically
significant (Figure 3c). Flt-4 is considered as a surface marker
for lymphatic endothelial vessels. The ligands for Flt-4 are
VEGF-C and VEGF-D (Joukov et al., 1996). We observed
increased expression of Flt-4 mRNA in the adjacent tumor-
bearing skin compared with normal skin, but this was not
statistically significant (Figure 3d). It may be that Prox and Flt-4
are regulated at the translational rather than transcriptional
level. It is also possible that significant differences might
be observed by evaluating expression of lymphangiogenesis-
promoting factors by specific compartments of the tumor
microenvironment. Kubo et al. (2000) showed tumoral blood
vessels expressing Flt-4 in a nude mouse transplanted with rat
glioblastoma. In our system, direct evaluation of human SCC
and adjacent dermis showed that LYVE1þ cells did not
coexpress PAL-E or CD34 (Supplementary Figure S1 online),
indicating that these were lymphatics rather than blood vessels.
We used LCM to drill down on the inflammatory compo-
nent of the SCC microenvironment. We found increased
expression of VEGF-C and VEGF-D in peritumoral inflamma-
tory cells (Figure 4d and Supplementary Figure S4a online,
respectively). We also found increased expression of VEGF-C
and VEGF-D in invasive SCC with little or no expression
in situ or precursor AK-likedysplasia, indicating that VEGF-C
expression by tumor cells may be a marker for transformation
from indolent to aggressive biological behavior. The relative
lack of inflammatory infiltrate associated with SCC in situ and
precursor AK-like dysplasia lesions in this study raises questions
regarding the potential for crosstalk between SCC and associated
inflammatory cells in driving aggressive biological behavior. This
relationship is the subject of ongoing studies by our group.
We found CD163þCD68þVEGF-Cþ cells associated with
SCC, indicating that tumor-associated macrophages may be
important mediators of lymphangiogenesis. Elucidating the
exact mechanisms whereby SCC induces lymphangiogenesis
may lead to the development of potential therapeutic targets
for locally advanced or inoperable SCC.
MATERIALS AND METHODS
Institutional Review Board approval (Weill Cornell Medical College)
and informed consent were obtained before enrolling patients to
participate in this study, and the study was performed with strict
adherence to the Declaration of Helsinki Principles.
Samples used in the study
Cutaneous, stage 1 (size o2 cm), well-differentiated SCCs from sun-
exposed regions (head, neck, dorsal hands) were obtained during
Mohs micrographic surgery. Ten normal specimens were obtained
from 3-mm punch biopsies from non-sun-exposed areas of normal
volunteers and from normal abdominoplasty tissue. Some of these
samples may have been used in previous studies as normal controls.
Gene set enrichment analysis
Microarray data for SCC have been published earlier by our group
(Haider et al., 2006). We evaluated fold change from three different
published lists, all available from http://www.broad.mit.edu/gsea/
index.jsp: (1) IRITANI ADPROX LYMPH, (127 LEC genes); (2)
Brentani Angiogenesis, (10 cancer-related angiogenesis genes); and
(3) VEGF PATHWAY (28 VEGF expression genes). We tested the
significance of gene expression findings from SCC, PTNL, and
normal skin by gene set enrichment analysis (Subramanian et al.,
2007). If the upregulated genes in the ‘‘SCC’’ list are ranked highly,
the enrichment scoreES will be near 1, if the opposite is true, then
the enrichment score value approaches 1. Because we were
working with several lists, a normalized enrichment score allowed
comparison between lists. Positive normalized enrichment score
corresponds to upregulation of a gene set, whereas negative values
correspond to downregulation.
RNA isolation and quantitation
Samples were snap-frozen and stored in liquid nitrogen. Individual
frozen samples were placed in 1ml of room temperature RLT buffer
with 1% b-mercaptoethanol (Qiagen, Valencia, CA) and immedi-
ately homogenized at full power for 30 seconds using a PowerGen
1000 homogenizer (Fisher Scientific, Pittsburgh, PA). Homogenates
were sonicated on ice for 20 seconds at full power. DNA was
removed with on-column DNAse digestion using an RNAse-free
DNAse Set (Qiagen). RNA was isolated using the RNeasy Mini Kit
(Qiagen) according to the manufacturer’s recommendations. Total
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RNA concentration and purity was evaluated using an Ultraspec
2100 prospectrophotometer (Amersham Biosciences, Piscataway,
NJ) or Nanodrop 1000 (Thermo Scientific, Rockford, IL).
RT-PCR
The primers and probes for human IL-8 (Hs00174103_m1),
VEGF-C (Hs00153458m1), VEGF-D (Hs00174103_m1), Prox-1
(Hs00160463_m1), PDPN (Hs00362718_m1), NRP-2 (Hs010330070_
m1), and Flt-4 (Hs01047679) were determined by TaqMan RT-PCR
individual assays designed by Applied Biosystems (Foster City, CA).
The sequences of the primers and probes for human acidic ribosomal
protein (HARP) are HARP-forward, CGCTGCTGAACATGCTCAA,
HARP-reverse, TGTCGAACACCTGCTGGATG; HARP-probe, 6-FAM-
TCCCCCTTCTCCTTTGGGCTGG-TAMRA (GenBank accession no.
NM-001002). The RT-PCR reaction was performed using 10 ng total
RNA and EZ PCR Core Reagents (Applied Biosystems) according
to the manufacturer’s directions. The samples were amplified and
quantified on an Applied Biosystems PRISM 7900 HT using the
following thermal cycler conditions: 2minutes at 50 1C, 30minutes
at 60 1C, 5minutes at 95 1C; and 40 cycles of 15 seconds at 95 1C,
followed by 60 seconds at 60 1C. Each sample and gene was
normalized to HARP. Data were analyzed and samples quantified by
software provided with the Applied Biosystems PRISM 7900 HT.
Statistical analysis between each condition was performed using
Student’s t-test in Prism.
Immunohistochemistry
We stained sections with hematoxylin (Fisher, Fair Lawn, NJ) and
eosin (Shandon, Pittsburgh, PA) and purified rabbit antihuman
polyclonal antibodies to LYVE-1 (Abcam, Cambridge, MA; all at
1:100), and antihuman antibody to VEGFR-3 (Clone 9D9F, Milli-
pore, Billerica, MA; 1:100) and VEGF-C (Santa Cruz, CA; sc1881,
1:100). Biotin-labeled horse antimouse antibody, biotin-labeled goat
antirabbit antibody, and biotin-labeled rabbit antigoat (Vector
Laboratories, Burlingame, CA) were amplified with the avidin–biotin
peroxidase complex (Vector Laboratories, Burlingame, CA) and
developed with chromogen 3-amino-9-ethylcarbazole (Sigma-
Aldrich, St Louis, MO). Counterstaining was performed with light
green (Sigma-Aldrich).
Immunofluorescence
Specimens were fixed in 100% acetone for 5minutes (n¼ 5).
Nonspecific staining was blocked with 10% normal chicken serum
(Vector Laboratories). Tissue was then stained overnight at 4 1C with
two primary antibodies: (1) murine anti-VEGFR3 (clone 9D9F9,
1:100, Millipore) and (2) LYVE-1 purified polyclonal rabbit antibody
(1:100, Abcam); (1) polyclonal rabbit antihuman VEGF-C (1/500) or
(1) mouse monoclonal IgG1 antibody to VEGF-D (Abcam, 1/100)
and (2) mouse antihuman CD163-FITC. The following day, slides
were washed and labeled with secondary antibody (VEGFR-3/LYVE-
1) conjugates for 30minutes at room temperature: (1) goat antimouse
IgG1 Alexa-488 and (2) chicken antirabbit Alexa-594. Secondary
antibodies used against VEGF-C and VEGF-D were Alexa-594
chicken antigoat (1/250) and Alexa-568 goat antimouse IgG1 (1/250),
respectively. Amplification/detection systems were from Invitrogen/
Molecular Probes (Eugene, OR). Images were acquired using appro-
priate filters of a Zeiss Axioplan 2 wide-field fluorescence microscope
fitted with a PlanNeofluar X10/0.30 N.A. objective lens and a
Hamamatsu Orca ER CCD camera (Hamamatsu, Bridgewater, NJ)
controlled by MetaVue software (MDS Analytical Technologies,
Downington, PA). VEGFR-3þ lymphatic vessels and CD163þ cells
were visualized using an FITC filter set, LYVE-1 LECs and VEGF-C/D
were visualized with a Texas red filter set. Images in the figure are
presented both as single monochrome images and in pseudocolor
(green, red) located above the merged image, so that one can
appreciate the localization of markers on similar or different cells.
Red and green overlapping cells appear yellow. Size bar¼ 100mm.
Double-labeled immunofluorescence was performed as above
with the following antibodies: CD68 (Clone Y1/82A, 1/100, BD
Pharmingen, San Jose, CA), CD11c (B-ly6, 1/100, BD Pharmingen),
VEGF-C (clone 107/F10, 1/100, Novus Biologicals, Littleton, CO),
CD34-FITC (mouse monoclonal IgG1, 1/50, BD Pharmingen), PAL-E
(mouse monoclonal IgG1, 1/50, Abcam), LYVE-1 rabbit polyclonal
IgG, 1/100, Abcam), anti-FITC (goat antimouse, 1/250, Invitrogen),
Alexa Fluor-488 (goat antimouse, 1/250, Invitrogen), Rhodamine
Red-X (Goat antirabbit IgG, 1/250, Invitrogen). Red and green
overlapping cells appear yellow. Size bar¼ 100mm.
For triple-labeled immunofluorescence, specimens were incu-
bated with polyclonal goat antihuman VEGF-C (Clone sc-1881,
1/100, Santa Cruz), washed and incubated with chicken antigoat
Alexa-594. Sections were then washed and stained with mouse
antihuman CD68 monoclonal antibody (Clone Y1/82A, 1/100, BD
Pharmingen) and stained with goat antihuman IgG2b Alexa-488.
Sections were washed and stained with mouse antihuman CD163
mAb labeled with Zenon Alexa Fluor-647 Mouse IgG1. VEGF-C was
visualized with a Texas red, CD68 with a green, and CD163 with
Cy5 filter set. Red and green overlapping cells appear yellow in
color, red and blue appear purple, and green and blue appear aqua;
cells labeled with all three stains appear white.
Image analysis
For immunohistochemistry, positive cells were counted manually in
a blinded manner, and area measures were computed by computer-
assisted image analysis, NIH software (NIH IMAGE J, Washington,
DC). Lymphatic vessels were defined as LYVE1þ lumina lined with
few endothelial cells. Cell counts per unit area (mm2 100,000)
were determined within juxtatumoral dermis. In all cases, tumor
sections with representative response were selected for analysis.
Statistical analysis was performed with Student’s t-test.
Laser capture microdissection
Samples were immediately frozen and stored at 80 1C. Sections
were cut into 8 mm sections in a 20 1C cryostat, mounted on slides,
and stored at 80 1C. Slides were immersed in 70% ethanol after
removal from freezer. Hematoxylin and eosin staining was performed as
follows: 70% ethanol for 30 seconds, RNase-free water for 10 seconds,
hematoxylin for 10 seconds, RNase-free water for 10 seconds, 70%
ethanol for 10 seconds, eosin for 10 seconds, followed by dehydra-
tion for 1minute in 90%, 100% ethanol and citrisolve buffer. Slides
were air dried for 5minutes. LCM was performed according to the
manufacturer’s protocol (CellCut system, Molecular Machines and
Industries, Haslett, MI). LCM cells were placed rapidly into 100 ml of
RLT buffer with 1% b-mercaptoethanol after removal from freezer
to prevent RNA degradation, and stored at 80 1C until extraction
was performed. We collected cells of interest from SCC, AK-like
dysplasia, and inflammatory cells adjacent to tumors.
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RNA extraction and quantification for LCM
Total RNA was extracted into 24 ml of RNase-free water using
an RNeasy Micro Kit (Qiagen) according to the manufacturer’s
protocol. DNA was removed with DNase digestion using an RNase-
free DNase kit (Qiagen).
Quantitative RT-PCR
First-strand cDNA synthesis was performed with SuperScriptIII and
Random Primers (Invitrogen, Carlsbad, CA). A volume of 2 ng of total
RNA was dissolved in 19.0ml of cDNA synthesis reaction containing
1.0 ml of RNAsin (Promega, Madison, WI). A volume of 2ml of the
resulting cDNA synthesis was used per quantitative PCR reaction.
TaqMan Universal PCR Master Mix (Applied Biosystems) was used.
Samples were analyzed in duplicate. Quantitative RT-PCR was
performed using the 7900HT Fast Real-Time PCR System (Applied
Biosystems). Thermal cycler conditions: 2minutes at 50 1C, 5minutes
at 95 1C, and 45 cycles of 15 seconds at 95 1C, followed by 60 seconds
at 60 1C. All values were normalized to HARP. Primers and probes
sequences were listed previously. Statistical analysis between groups
was carried out using Prism Software one-way analysis of variance
and Tukey’s multiple comparison test.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This research was supported by the Dana Foundation (Human Immunology
Consortium Grant), which supports JAC, DM, and KCP. HM, MSF, and
KNS are partially funded by the Milstein Medical Program at Rockefeller
University. MSF is partially support by the NIH Grant UL1 RR024143 from
National Center for Research Resources. MJB is supported by NIH Grant
T32-HL07423. We thank Israel Coats, Shawn Galdeen, and Shivaprasad
Bhuvanendran for technical assistance.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Baek SK, Jung KY, Lee SH et al. (2009) Prognostic significance of vascular
endothelial growth factor-C expression and lymphatic vessel density in
supraglottic squamous cell carcinoma. Laryngoscope 119:1325–30
Banerji S, Ni J, Wang SX et al. (1999) LYVE-1, a new homologue of the CD44
glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol
144:789–801
Bluth MJ, Zaba LC, Moussai D et al. (2009) Myeloid dendritic cells from
human cutaneous squamous cell carcinoma are poor stimulators of
T-cell proliferation. J Invest Dermatol 129:2451–62
Bono P, Wasenius VM, Heikkila¨ P et al. (2004) High LYVE-1-positive
lymphatic vessel numbers are associated with poor outcome in breast
cancer. Clin Cancer Res 10:7144–9
Boone B, Blokx W, De Bacquer D et al. (2008) The role of VEGF-C staining in
predicting regional metastasis in melanoma. Virchows Arch 453:257–65
Cao Y, Linden P, Farnebo J et al. (1998) Vascular endothelial growth factor C
induces angiogenesis in vivo. Proc Natl Acad Sci USA 95:14389–94
Caunt M, Mak J, Liang WC et al. (2008) Blocking neuropilin-2 function
inhibits tumor cell metastasis. Cancer Cell 13:331–42
Cueni LN, Detmar M (2009) Galectin-8 interacts with podoplanin and
modulates lymphatic endothelial cell functions. Exp Cell Res 315:1715–23
Cursiefen C, Chen L, Borges LP et al. (2004) VEGF-A stimulates lymphangio-
genesis and hemangiogenesis in inflammatory neovascularization via
macrophage recruitment. J Clin Invest 113:1040–50
Edge SB, Compton CC et al. (eds) (2010) In: AJCC Cancer Satgeing Manual,
7th edn. New York: Springer
Favier B, Alam A, Barron P et al. (2006) Neuropilin-2 interacts with VEGFR-2
and VEGFR-3 and promotes human endothelial cell survival and
migration. Blood 108:1243–50
Frech S, Ho¨rmann K, Riedel F et al. (2009) Lymphatic vessel density in
correlation to lymph node metastasis in head and neck squamous cell
carcinoma. Anticancer Res 29:1675–9
Groger M, Niederleithner H, Kerjaschki D et al. (2007) A previously unknown
dermal blood vessel phenotype in skin inflammation. J Invest Dermatol
127:2893–900
Haider AS, Peters SB, Kaporis H et al. (2006) Genomic analysis defines a
cancer-specific gene expression signature for human squamous cell
carcinoma and distinguishes malignant hyperproliferation from benign
hyperplasia. J Invest Dermatol 126:869–81
Hamada K, Oike Y, Takakura N et al. (2000) VEGF-C signaling pathways
through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.
Blood 96:3793–800
Hamrah P, Chen L, Zhang Q et al. (2003) Novel expression of vascular
endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal
dendritic cells. Am J Pathol 163:57–68
Hirakawa S, Brown LF, Kodama S et al. (2007) VEGF-C-induced lymphan-
giogenesis in sentinel lymph nodes promotes tumor metastasis to distant
sites. Blood 109:1010–7
Joukov V, Pajusola K, Kaipainen A et al. (1996) A novel vascular endothelial
growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR
(VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–8
Karpanen T, Egeblad M, Karkkainen MJ et al. (2001) Vascular endothelial
growth factor C promotes tumor lymphangiogenesis and intralymphatic
tumor growth. Cancer Res 61:1786–90
Kataru RP, Jung K, Jang C et al. (2009) Critical role of CD11b+ macrophages
and VEGF in inflammatory lymphangiogenesis, antigen clearance, and
inflammation resolution. Blood 113:5650–9
Kubo H, Fujiwara T, Jussila L et al. (2000) Involvement of vascular endothelial
growth factor receptor-3 in maintenance of integrity of endothelial cell
lining during tumor angiogenesis. Blood 96:546–53
Rosenkilde MM, Schwartz TW (2004) The chemokine system – a major
regulator of angiogenesis in health and disease. APMIS 112:481–95
Schoppmann SF, Birner P, Sto¨ckl J et al. (2002) Tumor-associated
macrophages express lymphatic endothelial growth factors and
are related to peritumoral lymphangiogenesis. Am J Pathol 161:
947–56
Subramanian A, Kuehn H, Gould J et al. (2007) GSEA-P: a desktop application
for gene set enrichment analysis. Bioinformatics 23:3251–3
Sugiura T, Inoue Y, Matsuki R et al. (2009) VEGF-C and VEGF-D expression is
correlated with lymphatic vessel density and lymph node metastasis in
oral squamous cell carcinoma: Implications for use as a prognostic
marker. Int J Oncol 34:673–80
Veness MJ, Palme CE, Morgan GJ (2006) High-risk cutaneous squamous cell
carcinoma of the head and neck: results from 266 treated patients with
metastatic lymph node disease. Cancer 106:2389–96
Watari K, Nakao S, Fotovati A et al. (2008) Role of macrophages in
inflammatory lymphangiogenesis: Enhanced production of vascular
endothelial growth factor C and D through NF-kappaB activation.
Biochem Biophys Res Commun 377:826–31
Weinberg AS, Ogle CA, Shim EK (2007) Metastatic cutaneous squamous cell
carcinoma: an update. Dermatol Surg 33:885–99
Wigle JT, Oliver G (1999) Prox1 function is required for the development of
the murine lymphatic system. Cell 98:769–78
Yuan L, Moyon D, Pardanaud L et al. (2002) Abnormal lymphatic
vessel development in neuropilin 2 mutant mice. Development
129:4797–806
Zaba LC, Fuentes-Duculan J, Steinman RM et al. (2007) Normal
human dermis contains distinct populations of CD11c+BDCA-1+
dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest
117:2517–25
236 Journal of Investigative Dermatology (2011), Volume 131
D Moussai et al.
Cutaneous SCC Is Characterized by Increased LVD
